Rapid Micro Biosystems Affirms FY2026 Sales Guidance of $37.000M-$41.000M vs $39.133M Est

Benzinga Newsdesk www.benzinga.com Negative 71.3%

Neg 71.3% Neu 0% Pos 0%

Rapid Micro Biosystems (NASDAQ:RPID) affirms FY2026 sales outlook from $37.000 million-$41.000 million to $37.000 million-$41.000 million vs $39.133 million estimate.